|
US2014045894A1
|
|
Methods for delivering a drug to a hospital patient for short-term use while minimizing long-term use of the drug
|
|
AU2012216319A1
|
|
Spirocyclic heterocyclic derivatives and methods of their use
|
|
AU2012284127A1
|
|
Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto
|
|
AU2011203123A1
|
|
Substituted piperidine compounds and methods of their use
|
|
US2010311782A1
|
|
Substituted piperidinylpropanoic acid compounds and methods of their use
|
|
NZ594937A
|
|
Beloxepin, its enantiomers, and analogs thereof for the treatment of pain
|
|
US2009233958A1
|
|
(+)-beloxepin and methods for its synthesis and use
|
|
US2009233957A1
|
|
(-)-beloxepin and methods for its synthesis and use
|
|
US2009233959A1
|
|
Beloxepin and analogs for the treatment of pain
|
|
CN101720186A
|
|
Compositions of (-)-e-10-oh-nt and methods for their synthesis and use
|
|
WO2008063625A2
|
|
Pyridine compounds and methods of their use
|
|
EP2063886A2
|
|
Use of n-containing spirocompounds for the enhancement of cognitive function
|
|
CN101415423A
|
|
Spirocyclic heterocyclic derivatives and methods of their use
|
|
US2007269374A1
|
|
Spirocyclic heterocyclic derivatives and methods of their use
|
|
US2008058302A1
|
|
Sulfamoyl benzamides and methods of their use
|
|
US2007105863A1
|
|
Opioid antagonists
|
|
CN101365448A
|
|
Compositions containing opioid antagonists
|
|
US2007092576A1
|
|
Compositions containing opioid antagonists
|
|
CN101355942A
|
|
Solid dispersions of opioid antagonists
|
|
US2007082053A1
|
|
Solid dispersions of opioid antagonists
|
